CysC Fast Test Kit

CysC Fast Test Kit

Getein CysC Fast Test Kit enables fast and accurate quantification of Cystatin C in serum, plasma, or whole blood to assess renal function within 3 minutes.

Description

CysC Fast Test Kit (Immunofluorescence Assay)

The CysC Fast Test Kit is a quantitative immunofluorescence assay designed for rapid detection of Cystatin C (CysC) levels in serum, plasma, or whole blood. It serves as a valuable tool in assessing kidney function and monitoring glomerular filtration rate (GFR), especially in patients with kidney disease, transplant cases, or chemotherapy monitoring.

Key Advantages

  • Fast Turnaround: Delivers results in just 3 minutes
  • Accurate Kidney Function Indicator: Cystatin C is more reliable than creatinine for GFR estimation
  • Early Detection: Useful in early diagnosis of renal damage and acute kidney injury (AKI)
  • Versatile Sample Use: Works with serum, plasma, and whole blood
  • Stable Storage: 4–30°C for up to 24 months

About Cystatin C (CysC)

Cystatin C is a small protein filtered by the glomeruli and reabsorbed and degraded in the renal tubules. Unlike creatinine, it is not affected by muscle mass, making it a more accurate marker for kidney function. Increased levels in blood indicate reduced kidney filtration capacity, often before creatinine levels rise.

Specifications

Parameter Details
Test Item Cystatin C (CysC)
Sample Type Serum, Plasma, Whole Blood
Detection Method Immunofluorescence Assay
Detection Range 0.5–10.0 mg/L
Cut-off Value 0.51–1.09 mg/L
Test Time 3 Minutes
Storage Conditions 4–30°C
Shelf Life 24 Months

Compatible Devices

  • Getein 1100 Immunofluorescence Quantitative Analyzer
  • Getein 1160 Immunofluorescence Quantitative Analyzer
  • Getein 1180 Immunofluorescence Quantitative Analyzer
  • Getein 1200 Immunofluorescence Quantitative Analyzer
  • Getein 1600 Immunofluorescence Quantitative Analyzer

Clinical Applications

  • Early diagnosis of kidney disease
  • Renal function monitoring in transplant and chemotherapy patients
  • Detection of acute kidney injury (AKI) in high-risk groups
  • Evaluation of kidney function in liver cirrhosis cases